
Loading, please wait...

Loading, please wait...

Managing post-surgical urinary incontinence is a critical priority for urologists treating benign prostatic hyperplasia (BPH). While clinical trials provide controlled data, real-world evidence (RWE) offers a broader perspective on diverse practice settings. A recent large-scale retrospective study analyzed data from nearly 98,000 men. These patients underwent various BPH treatments between 2017 and 2024. The study aimed to clarify how often incontinence occurs and which factors prolong its duration.
The research reveals that 6.9% of patients experienced incontinence within one month of surgery. Fortunately, these rates significantly decline over time. By 18 months, the incidence dropped to 3.8%. After three years, only 2.3% of patients reported persistent symptoms. These findings suggest that most post-operative leakage is transient. However, identifying the small percentage of patients at risk for long-term issues remains essential for preoperative counseling.
The study highlighted several independent risk factors for persistent incontinence lasting up to three years. Patients with polyuria faced the highest risk, followed by those with obesity (BMI ≥ 30). Furthermore, older age significantly increased the likelihood of long-term complications. Researchers also noted variations between surgical modalities. For instance, endoscopic enucleation was associated with higher persistent rates compared to transurethral resection of the prostate (TURP).
Urologists should use this real-world data to refine patient selection and counseling. Addressing comorbidities like obesity and managing polyuria before surgery might improve outcomes. Additionally, the study emphasizes that while enucleation offers advantages in tissue removal, surgeons must carefully discuss the potential for prolonged recovery. This comprehensive view helps set realistic expectations for patients undergoing BPH interventions.
Most cases resolve within 18 months. Real-world data shows that while 6.9% have early symptoms, only 2.3% experience persistent leakage after three years.
The primary risk factors include polyuria, obesity, and advanced age. Patients undergoing endoscopic enucleation also showed higher rates of persistent symptoms in this study.
Yes. Data indicates that endoscopic enucleation carries a higher risk of persistent incontinence compared to TURP, highlighting the need for specialized surgical counseling.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A large-scale study uses real-world evidence to track post-surgical urinary incontinence rates and risk factors in men treated for BPH from 2017 to 2024....
7 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today